FIORAVANTI, ANNA
 Distribuzione geografica
Continente #
NA - Nord America 320
EU - Europa 206
AS - Asia 75
AF - Africa 12
OC - Oceania 10
SA - Sud America 1
Totale 624
Nazione #
US - Stati Uniti d'America 314
FR - Francia 97
IT - Italia 75
CN - Cina 27
VN - Vietnam 25
AU - Australia 10
EG - Egitto 10
GB - Regno Unito 8
DE - Germania 7
CA - Canada 6
JP - Giappone 4
PL - Polonia 3
SG - Singapore 3
TR - Turchia 3
DK - Danimarca 2
HK - Hong Kong 2
IE - Irlanda 2
RU - Federazione Russa 2
SA - Arabia Saudita 2
TW - Taiwan 2
UA - Ucraina 2
AM - Armenia 1
BD - Bangladesh 1
CH - Svizzera 1
CL - Cile 1
CZ - Repubblica Ceca 1
ES - Italia 1
FI - Finlandia 1
HU - Ungheria 1
IL - Israele 1
IN - India 1
KR - Corea 1
LB - Libano 1
LT - Lituania 1
MA - Marocco 1
NL - Olanda 1
SE - Svezia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 624
Città #
Serra 52
Houston 36
Dong Ket 23
Fairfield 23
Ashburn 22
Woodbridge 22
Buffalo 18
Seattle 15
Ann Arbor 14
Wilmington 14
Santa Cruz 12
Cairo 10
Cambridge 10
El Paso 10
Chicago 9
Perth 9
Paris 7
San Francisco 5
Shanghai 5
Boardman 4
Dallas 4
Des Moines 4
Guangzhou 4
Los Angeles 4
Mountain View 4
Phoenix 4
Wuhan 4
Beijing 3
Bremen 3
Gaeta 3
Memphis 3
Milpitas 3
San Jose 3
Annandale 2
Bordeaux 2
Dalian 2
Dublin 2
Hong Kong 2
Lake Forest 2
Las Vegas 2
Madison 2
Ottawa 2
Pobeda 2
Riva 2
Riyadh 2
Rome 2
Singapore 2
Torcy 2
Toronto 2
Ankara 1
Bengaluru 1
Beverly Hills 1
Boulder 1
Büdelsdorf 1
Capannori 1
Capoterra 1
Cardiff 1
Changsha 1
Charlottesville 1
Chengdu 1
Columbus 1
Conselve 1
Coventry 1
Denver 1
Frankfurt am Main 1
Gangnam-gu 1
Gdansk 1
Groningen 1
Hamilton 1
Hangzhou 1
Helsinki 1
Istanbul 1
Kaohsiung City 1
Leeds 1
Lombard 1
London 1
Madrid 1
Margate 1
Milwaukee 1
Montreal 1
Muizenberg 1
New York 1
Oria 1
Otemae 1
Pasadena 1
Petah Tikva 1
Philadelphia 1
Portland 1
Providence 1
Rangpur City 1
Rochester 1
Rueil-Malmaison 1
San Diego 1
Shenyang 1
Shenzhen 1
Suita 1
Szeged 1
Taichung 1
Tampa 1
Tappahannock 1
Totale 449
Nome #
Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2, file e0d6c92b-95cd-fcf8-e053-d805fe0aa794 193
Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients, file e0d6c931-1d35-fcf8-e053-d805fe0aa794 144
null, file e0d6c927-e576-fcf8-e053-d805fe0aa794 85
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo, file e0d6c92a-e9af-fcf8-e053-d805fe0aa794 76
1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions, file e0d6c92b-9be1-fcf8-e053-d805fe0aa794 74
VEGF-A polymorphisms predict short-term functional response to intravitreal ranibizumab in exudative age-related macular degeneration, file e0d6c926-38de-fcf8-e053-d805fe0aa794 9
CLM3, a multitarget tyrosine kinase inhibitor with antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo, file e0d6c926-4180-fcf8-e053-d805fe0aa794 8
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo, file e0d6c926-4715-fcf8-e053-d805fe0aa794 7
Genetic interaction of P2X7 receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients, file e0d6c92b-384d-fcf8-e053-d805fe0aa794 7
Structure-Based Optimization of Tyrosine Kinase Inhibitor CLM3. Design, Synthesis, Functional Evaluation, and Molecular Modeling Studies., file e0d6c926-4182-fcf8-e053-d805fe0aa794 5
Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients, file e0d6c927-f523-fcf8-e053-d805fe0aa794 5
1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions, file e0d6c929-6677-fcf8-e053-d805fe0aa794 4
Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers, file e0d6c92a-b1ad-fcf8-e053-d805fe0aa794 4
Aurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancer, file e0d6c926-0e7c-fcf8-e053-d805fe0aa794 3
Metronomic ceramide analogs inhibit angiogenesis in pancreatic cancer through up-regulation of caveolin-1 and thrombospondin-1 and down-regulation of cyclin D1, file e0d6c926-2507-fcf8-e053-d805fe0aa794 3
Antiproliferative and Proapoptotic Activity of Sunitinib on Endothelial and Anaplastic Thyroid Cancer Cells via Inhibition of Akt and ERK1/2 Phosphorylation and by Down-Regulation of Cyclin-D1., file e0d6c926-37ee-fcf8-e053-d805fe0aa794 3
Irinotecan synergistically enhances the antiproliferative and proapoptotic effects of axitinib in vitro and improves its anticancer activity in vivo., file e0d6c926-3fad-fcf8-e053-d805fe0aa794 3
A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients., file e0d6c926-3fb5-fcf8-e053-d805fe0aa794 3
The rs2071559 AA VEGFR-2 genotype frequency is significantly lower in neovascular age-related macular degeneration patients., file e0d6c926-3fab-fcf8-e053-d805fe0aa794 2
Pharmacogenetic interaction analysis of VEGFR-2 and IL-8 polymorphisms in advanced breast cancer patients treated with paclitaxel and bevacizumab., file e0d6c926-4256-fcf8-e053-d805fe0aa794 2
Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells, file e0d6c929-ef88-fcf8-e053-d805fe0aa794 2
Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2, file e0d6c92b-95ce-fcf8-e053-d805fe0aa794 2
null, file e0d6c92b-f07b-fcf8-e053-d805fe0aa794 2
Docetaxel plus oral metronomic cyclophosphamide: A phase II study with pharmacodynamic and pharmacogenetic analyses in castration-resistant prostate cancer patients, file e0d6c926-44a5-fcf8-e053-d805fe0aa794 1
Totale 647
Categoria #
all - tutte 1.459
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.459


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201935 0 0 0 0 0 0 0 0 0 4 18 13
2019/2020110 9 8 5 14 9 8 7 8 17 14 6 5
2020/2021116 5 5 3 4 7 18 9 4 9 13 14 25
2021/202285 4 7 8 18 12 4 2 2 4 1 15 8
2022/2023112 3 13 19 11 11 13 6 7 6 4 14 5
2023/2024172 9 10 10 8 14 35 36 41 3 6 0 0
Totale 647